ProTreatment Tinglev ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 4.1% 8.0% 8.9% 6.0%  
Credit score (0-100)  0 49 29 27 38  
Credit rating  N/A BBB BB BB BBB  
Credit limit (kDKK)  0.0 -0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 342 738 415 682  
EBITDA  0.0 49.4 164 78.9 211  
EBIT  0.0 -83.9 -240 -339 -214  
Pre-tax profit (PTP)  0.0 -129.3 -335.7 -456.5 -408.4  
Net earnings  0.0 -101.0 -261.9 -356.2 -318.6  
Pre-tax profit without non-rec. items  0.0 -129 -336 -457 -408  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 233 204 238 163  
Shareholders equity total  0.0 -61.0 -323 -679 -998  
Interest-bearing liabilities  0.0 3,338 3,375 3,510 3,543  
Balance sheet total (assets)  0.0 3,877 3,565 3,229 2,868  

Net Debt  0.0 3,330 3,364 3,495 3,528  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 342 738 415 682  
Gross profit growth  0.0% 0.0% 116.1% -43.8% 64.3%  
Employees  0 2 2 1 1  
Employee growth %  0.0% 0.0% 0.0% -50.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 3,877 3,565 3,229 2,868  
Balance sheet change%  0.0% 0.0% -8.1% -9.4% -11.2%  
Added value  0.0 49.4 164.0 65.1 211.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 3,483 -783 -734 -850  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% -24.6% -32.5% -81.6% -31.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -2.1% -6.1% -8.7% -5.5%  
ROI %  0.0% -2.5% -7.1% -9.8% -6.1%  
ROE %  0.0% -2.6% -7.0% -10.5% -10.5%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% -1.7% -8.9% -18.4% -27.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 6,736.7% 2,051.0% 4,429.0% 1,668.3%  
Gearing %  0.0% -5,467.9% -1,045.0% -516.9% -355.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 2.7% 2.9% 3.4% 5.5%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.9 0.6 0.5 0.6  
Current Ratio  0.0 0.4 0.4 0.4 0.4  
Cash and cash equivalent  0.0 8.2 10.4 15.0 14.9  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -367.0 -501.8 -474.7 -471.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 25 82 65 211  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 25 82 79 211  
EBIT / employee  0 -42 -120 -339 -214  
Net earnings / employee  0 -51 -131 -356 -319